Weight loss drugs could help people with alcohol addiction, study suggests

2 months ago 43
ARTICLE AD BOX

Jabs used for weight loss and treating type 2 diabetes could help people with alcohol abuse problems, according to a study.

The injections led to a 50% lower rate of alcohol intoxication in people taking them compared to those who had not been prescribed them, researchers found.

They also found off-label use of the drugs could help people addicted to opioids.

In a study published in the journal Addiction, the researchers looked at glucagon-like peptide-1 receptor agonists (GLP-1 RA), which they said included the drug Ozempic, and/or glucose-dependent insulinotropic polypeptide (GIP) drugs, which they said include brand name Mounjaro.

Such drugs may help curb addictions because, in addition to working on appetite, they also affect parts of the brain which maintain addictive behaviour, health experts suggest.

Researchers looked at 817,309 people with a history of alcohol use disorder, of which 5,621 had a prescription for a GLP-1 RA or GIP.

They found people with alcohol use disorder who had a GLP-1 RA or GIP prescription had a 50% lower rate of alcohol intoxication compared to those who did not.

Read more:
Warning over using weight loss drugs to get 'beach body'
Ozempic to Wegovy: benefits and downsides
Wegovy supply issues as private clinics stockpile

Spreaker This content is provided by Spreaker, which may be using cookies and other technologies. To show you this content, we need your permission to use cookies. You can use the buttons below to amend your preferences to enable Spreaker cookies or to allow those cookies just once. You can change your settings at any time via the Privacy Options. Unfortunately we have been unable to verify if you have consented to Spreaker cookies. To view this content you can use the button below to allow Spreaker cookies for this session only.

👉 Click to subscribe to the Sky News Daily wherever you get your podcasts 👈

Drugs could help people with opioid addictions

The study, led by Loyola University Chicago in the US, also looked at 503,747 people with a history of opioid use disorder, of which 8,103 had been prescribed a GLP-1 RA or GIP.

It found people with the disorder who had a GLP-1 RA or GIP prescription had a 40% lower use of opioid overdose.

The results showed the drugs "should be investigated as a novel pharmacotherapy treatment option" for people with alcohol and opioid addiction," the authors said.

Please use Chrome browser for a more accessible video player

'Shouldn't use weight loss jabs as cosmetic drugs'

It comes after Health Secretary Wes Streeting told Sky News weight loss jabs such as Ozempic and Wegovy should not be used to get the "Instagram perfect body".

And Sir Keir Starmer said such treatments could get people "back to work" to boost the economy.

The prime minister also said the injections could also help reduce pressure on the NHS.

Read Entire Article